Life-Sciences-Germany.com
The Life Sciences Web Portal for German-speaking Europe

This is a free web portal for the life sciences in German-speaking Europe... » read more

Genentech Acquires CDK Inhibitors from Regor: $850m Upfront (2024-09-30)
Genentech will acquire Regor's next-generation CDK inhibitors for an upfront payment of $850 million in cash. Regor is also eligible to receive additional cash payments contingent on achieving future development, regulatory and commercial milestones Cambridge, M...
Evotec & Novo Nordisk: Cell Therapy Tech Development (2024-09-26)
Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced to...
Launch of Aptadir Therapeutics to Develop RNA Inhibitors (2024-09-24)
> A novel approach for intractable cancers and genetic conditions > Science originates from 3 top international institutions – the Beth Israel Deaconess Medical Center of the Harvard Medical School, the Italian Research National Council (CNR) and the Cancer Sc...
Andreas Eckert on the IPO of Pentixapharm at FSE – Interview (2024-09-24)
First German Life Sciences IPO since 2016 – Radiopharma Company Pentixapharm Lists at Frankfurt Stock Exchange A dewy interview by |transkript.de/Georg Kääb with Andreas Eckert, Chair of Pentixapharm and major shareholder of Eckert & Ziegler AG Pentixa...
Generate:Biomedicines & Novartis: Multi-target Collaboration (2024-09-24)
Potential total transaction valued at more than $1 billion with $65 million in total upfront consideration Generate:Biomedicines (“Generate”) today announced a multi-target collaboration with Novartis (NYSE: NVS) to discover and develop protein therapeutic...
Altaris to Acquire Minaris Regenerative from Resonac Corp (2024-09-24)
Resonac Corporation (President: Hidehito Takahashi, hereinafter called “REC”), announces that it has entered into a definitive share purchase agreement (hereinafter called “this deal”) to transfer all of the issued shares in Minaris Regenerative Medicine, L...
Minaris Regenerative Medicine to Be Acquired by Altaris (2024-09-24)
Minaris Regenerative Medicine (“Minaris”), a leading cell therapy contract development and manufacturing organization, is pleased to announce that its parent company, Resonac Corporation (“Resonac”), has entered into a definitive agreement to sell Minaris t...
BRAIN Biotech: up to €128.88m Deal with Royalty Pharma (2024-09-20)
> Total transaction value up to EUR 128.88 million significantly exceeding current market capitalization of BRAIN Biotech > Immediate upfront payment of EUR 18.41 million > Royalty monetization of an investigational compound, deucrictibant, with market leadin...
Symrise & Shan Foods Open Production Facility in Pakistan (2024-09-20)
> Ensures speed to market with the established local manufacturing footprint to Symrise key customers > To harness authentic and “hyperlocal” Pakistani flavours by embedding sustainability aspects > Collaboration with Shan Foods for innovation through cre...
Halix B.V. Appoints Lutz Hilbrich as New CEO (2024-09-19)
HALIX B.V., a leading contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of complex therapeutic antibodies (proteins) and viral products, is pleased to announce the appointment of Dr. Lutz Hilbrich as its ne...

» Show all News!

Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!

[LSG] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Germany, Austria and Switzerland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top